ANTHONY ADDAE: Open Payments
NPI 1962964791 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$872 in 31 payments from 8 companies in 2025. Trend: 2023 $132 · 2024 $817 · 2025 $872
Food & beverage: $613Education: $259
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $337 |
| Sumitomo Pharma America, Inc. | 11 | $212 |
| Otsuka America Pharmaceutical, Inc. | 5 | $106 |
| Lundbeck LLC | 3 | $78 |
| Paratek Pharmaceuticals, Inc. | 2 | $56 |
| SHIELD THERAPEUTICS INC | 1 | $41 |
| Novo Nordisk Inc | 1 | $26 |
| Lilly USA, LLC | 1 | $16 |
Products named: GEMTESA, REXULTI, Veozah, ACCRUFER, XHANCE, NUZYRA, MOUNJARO.
Industry payments across TX — which companies pay providers there.
